Mater Research is a recognised leader in medical research. Our bench to bedside philosophy sees us working across Mater Health’s hospitals and health services, The University of Queensland, and the world-class Translational Research Institute (TRI). We are committed to working closely with Mater Health, Mater Education and our growing network of partners and collaborators to turn scientific discovery into the best possible treatment, care, and outcomes for patients and our broader community.

Mater Research Institute - The University of Queensland (MRI-UQ) is an alliance between Mater Research and UQ, providing strategic benefits to both partners. Mater Research brings to the alliance considerable clinical collaboration opportunities and UQ brings all its expertise as a research, education, and teaching institution. Mater Research employees, through an affiliation to MRI-UQ have access to world-class research infrastructure and systems.

We continue to make great strides in medical research, read about our recent successes in our latest Annual Report.

 

Our key focus areas are Cancer , Chronic and Integrated Care , Healthcare Delivery and Innovation , Mother and Baby , Neuroscience .

Latest News

Every year in Australia almost 3,000 families experience the heartbreak of stillbirth or neonatal death.  The death of a baby—either during...

10

Apr

Providing support to bereaved families after stillbirth and neonatal death

Some of the greatest health disparities in Australia are experienced by people with intellectual disability due to mainstream health services...

07

Apr

Addressing the needs of Australians with Intellectual Disability

It is with mixed emotions that Mater Research says goodbye to Sonia Hancock, one of our strongest and most loyal supporters.

25

Mar

Sonia Hancock thanked for pivotal role at Mater Research

Mater Research is set to spearhead the development of a ground-breaking vaccine to treat ovarian cancer thanks to a $670,000 OCRF (Ovarian...

21

Mar

Queensland research team targets ovarian cancer vaccine

Mater Research is delighted to welcome Professor Kum Kum Khanna to Mater.  

20

Mar

Welcome Professor Kum Kum Khanna to Mater Research: A Pioneer in Women’s Cancer Research

For Mater Research Professional Research Fellow Professor Brian Gabrielli, taking on the Smiling for Smiddy Challenge cycling event is a...

14

Mar

Mater People ride to raise funds for cancer

Mater Research is breaking down health barriers for people with intellectual disability and those on the autism spectrum thanks to a new...

13

Mar

Program changes attitudes to patients with disabilities

2023 was an outstanding year for Mater Research with $13.7 million in grant funding received and 424 publications recorded.

29

Feb

Highlighting Mater Research’s year of achievements: 2023 Annual Report

A team of researchers from Mater Research and The University of Queensland have asked the question: “Does the gut microbiome play a role in...

28

Feb

Exploring the gut-brain connection in treatment-resistant schizophrenia

By reviewing data spanning nearly five decades, a team of Mater Researchers led by Associate Professor Kym Rae has identified that many...

27

Feb

Barriers to men’s participation in healthcare research